Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

NeoGenomics, Inc. (NEO)

Services-testing Laboratories

https://www.neogenomics.com

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.

9490 NEOGENOMICS WAY
FORT MYERS, FL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/25/1996

Market Cap

2,082,567,484

Shares Outstanding

127,470,000

Weighted SO

127,465,820

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

NTRA --.--%

QGEN --.--%

NEOG --.--%

GH --.--%

CDNA --.--%

MYGN --.--%

NVTA --.--%

CSTL --.--%

SYNH --.--%

Beta

1.1790

Last Div

0.0000

Range

11.03-21.22

Chg

0.1300

Avg Vol

777441

Mkt Cap

2082567484

Exch

NASDAQ

Country

US

Phone

239 768 0600

DCF Diff

29.6613

DCF

-13.3413

Div Yield

0.0000

P/S

3.3149

EV Multiple

-436.3433

P/FV

2.2427

Div Yield %

0.0000

P/E

-26.1516

PEG

-2.6822

Payout

0.0000

Current Ratio

2.0148

Quick Ratio

1.9347

Cash Ratio

1.2246

DSO

86.0322

DIO

23.0693

Op Cycle

109.1015

DPO

17.0788

CCC

92.0226

Gross Margin

0.4154

Op Margin

-0.1454

Pretax Margin

-0.1328

Net Margin

-0.1250

Eff Tax Rate

0.0586

ROA

-0.0478

ROE

-0.0843

ROCE

-0.0675

NI/EBT

0.9414

EBT/EBIT

0.9135

EBIT/Rev

-0.1454

Debt Ratio

0.3306

D/E

0.5931

LT Debt/Cap

0.2705

Total Debt/Cap

0.3723

Int Coverage

-41.6674

CF/Debt

0.0005

Equity Multi

1.7942

Rec Turnover

4.2426

Pay Turnover

21.3715

Inv Turnover

15.8219

FA Turnover

3.5731

Asset Turnover

0.3823

OCF/Share

0.0021

FCF/Share

-0.2352

Cash/Share

3.0684

OCF/Sales

0.0004

FCF/OCF

-112.6136

CF Coverage

0.0005

ST Coverage

0.0013

CapEx Coverage

0.0088

Div&CapEx Cov

0.0088

P/BV

2.2427

P/B

2.2427

P/S

3.3149

P/E

-26.1516

P/FCF

-70.0494

P/OCF

7780.6108

P/CF

7780.6108

PEG

-2.6822

P/S

3.3149

EV Multiple

-436.3433

P/FV

2.2427

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. May 17, 12:45 NeoVolta CEO Ardes Johnson Gives Expert Testimony to the US International Trade Commission Advising on Favorable Domestic Renewable Energy Policies Zacks Investment Research Jan 15, 18:32 Top Stock Picks for Week of January 15, 2024 Zacks Investment Research Jan 15, 18:32 Top Stock Picks for Week of January 15, 2024 Zacks Investment Research Jan 15, 18:32 Top Stock Picks for Week of January 15, 2024 Zacks Investment Research Jan 15, 18:32 Top Stock Picks for Week of January 15, 2024 Zacks Investment Research Jan 15, 18:32 Top Stock Picks for Week of January 15, 2024 Zacks Investment Research Jan 15, 18:32 Top Stock Picks for Week of January 15, 2024 Zacks Investment Research Jan 15, 18:32 Top Stock Picks for Week of January 15, 2024 Seeking Alpha Jan 04, 00:30 A Whole Lot Of Nothing At The Surface Seeking Alpha Jan 04, 00:30 A Whole Lot Of Nothing At The Surface Benzinga Dec 29, 09:20 Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday Benzinga Dec 28, 10:00 7 Analysts Have This To Say About NeoGenomics Benzinga Dec 28, 10:00 7 Analysts Have This To Say About NeoGenomics MarketWatch Dec 28, 07:46 Here's a 'solid contrarian idea' for 2024, according to BTIG's Krinsky MarketWatch Dec 28, 06:34 Here's a 'solid contrarian idea' for 2024, according to BTIG's Krinsky Seeking Alpha Dec 24, 01:02 Overbought Breadth Not Going Away Seeking Alpha Dec 24, 01:02 Overbought Breadth Not Going Away Seeking Alpha Dec 24, 01:02 Overbought Breadth Not Going Away Seeking Alpha Dec 24, 01:02 Overbought Breadth Not Going Away Zacks Investment Research Dec 18, 20:30 Quipt Home Medical Corp. (QIPT) Reports Q4 Loss, Misses Revenue Estimates

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.40 12/17/2020 12/15/2020 12/18/2020 12/30/2020